Recruiting at 1 site No phase Critical Illness

Clinical trial for Critical Illness

Official title A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

ClinicalTrials.gov ID: NCT06411561

What this study is testing

What it's testing
This study is testing whether combining sleep improvement and brain training can protect memory in older ICU survivors. It also looks at whether timing these activities with the body’s natural rhythm helps more.
Who it's for
You may be able to join if you are 60 or older, survived an ICU stay, and have some trouble remembering or sleeping.
What's involved
You would use a sleep aid device at home and do short brain‑training exercises on a tablet. You will also keep a sleep diary and answer simple questions about your day. The research team will check in with you by phone or online at set times.
Time commitment
The program lasts about 12 weeks. You will have a few short check‑ins each week and a final follow‑up after the program ends.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older

You may be able to join if

  • Age greater than or equal to 60 years old
  • Current hospitalization at University of Washington Medical Center or Harborview Medical Center
  • Intensive care unit (ICU) length of stay greater than 24 hours
  • Recovery from critical care status to acute care status, and/or discharge out of ICU
  • Fluent in English or Spanish

You likely can't join if

  • Documented history or suspicion of Alzheimer's disease or dementia, or current prescription of anti-dementia medication
  • Documented history of bipolar disorder or schizophrenia
  • Documented acute stroke or traumatic brain injury
  • Severe vision impairment
  • Severe hearing impairment
  • Severe paralysis or dominant arm paresis
See the full eligibility criteria
Who can join
  • Age greater than or equal to 60 years old
  • Current hospitalization at University of Washington Medical Center or Harborview Medical Center
  • Intensive care unit (ICU) length of stay greater than 24 hours
  • Recovery from critical care status to acute care status, and/or discharge out of ICU
  • Fluent in English or Spanish
  • Functional independence on activities of daily living prior to hospitalization (Katz Index = 6)
What rules you out
  • Documented history or suspicion of Alzheimer's disease or dementia, or current prescription of anti-dementia medication
  • Documented history of bipolar disorder or schizophrenia
  • Documented acute stroke or traumatic brain injury
  • Severe vision impairment
  • Severe hearing impairment
  • Severe paralysis or dominant arm paresis
  • Transfer from skilled nursing care facility or inpatient rehabilitation facility

The study team makes the final eligibility decision.

Where it is enrolling

  • Seattle, Washington, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.